Searched for
COMPUTING DEMANDS IN DRUG RESEARCH
ITR filing: Got Section 143(1) intimation after filing your income tax return? Here’s what it meansAfter filing your Income Tax Return, you may receive a Section 143(1) intimation notice. This notice confirms the tax department's prelimin...- Credit-deposit gap to persist as loan demand dynamics have changed, says SBI ResearchA noticeable gap between credit and deposit growth is troubling the banking landscape. Consumers are shifting their savings from traditiona...
- NASA climate data copied to Swiss supercomputer for AI training amid US funding cutsResearchers have copied massive quantities of publicly-available climate and environmental data from NASA onto a Swiss supercomputer to tra...
- Downfall of a Wall Street darling: Why Oracle shares crashed 65% from peakOracle shares have dropped about 65% from their peak as investors shift focus from AI-driven cloud growth to rising capital expenditure, de...
- Bristol Myers buys Nvidia's latest AI computing system for drug researchBristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery ...
- ETtech Explainer: Why Moonshot AI paused Kimi K3 subscriptions within days of launchChinese AI startup Moonshot AI has stopped new subscriptions for its Kimi K3 model. This decision follows a sharp surge in user demand for ...
- Big tech earnings to test AI rally as markets enter crucial weekBig Tech earnings from Alphabet, Tesla and Intel will test the AI rally as investors assess cloud growth, chip demand, capital spending, gu...
- IIT graduate once failed to qualifty for JEE. Today, he is the director of IIT Madras. Who is V Kamakoti?Now the director of IIT Madras, V Kamakoti's journey to success was anything but smooth. He did face some academic disappointments. He once...
- China's Moonshot AI pauses new Kimi K3 subscriptions amid surge in demandIn a social media post, Kimi AI stated the surge in demand over the last 48 hours has pushed the company's current capacity close to its li...
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
- "Initial glitch delayed Vikram-1 launch by 35 minutes, issue resolved quickly": ISRO ChairmanExplaining the reason behind the initial delay, Narayanan said the problem occurred during the transition from the ground segment to the on...
- Got AIR 35 in NEET-UG 2026 but won't become doctor: Here's why this topper chose engineering over medicine and will soon join IIT KharagpurSabyasachi Laskar, West Bengal's top NEET-UG scorer, will pursue computer science engineering at IIT Kharagpur. He aims to develop energy-e...
- Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killerIndia's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disea...
- Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley dealEli Lilly will acquire AtaiBeckley for up to $3.8 billion. This deal aims to develop psychedelic treatments for depression and other mental...
- India-UK FTA projected to boost Indian pharma exports by over 8% to $981 million in FY27: PharmexcilIndian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agre...
- Weight-loss drugmaker Lilly nears $1.97 bn AtaiBeckley's acquisition: ReportEli Lilly is reportedly negotiating to acquire psychedelic drugmaker AtaiBeckley. AtaiBeckley shares experienced a significant surge follow...
- Can America lag China in the AI race? A new threat is cropping upThe pause on data center construction in New York reveals a significant conflict between the accelerating demand for AI and the limitations...
- Fatty liver new treatment found: Study discovers a medicine that reverses severe fatty liver by just repairing the gutA new experimental drug shows promise for severe fatty liver disease. This compound targets the gut, not the liver directly. It repairs a d...
- AI startup Reflection signs over $1 billion computing deal with NebiusThe move builds on Reflection's June agreement with SpaceX for computing capacity, a deal that media reports said would see the startup p...
- Pharma body renews push for data protectionLeading pharmaceutical companies seek Regulatory Data Protection to boost research investments. Public health groups and local makers oppos...
Load More
